To Compare Efficacy and Safety between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients
- Conditions
- Diseases of the musculo-skeletal system and connective tissue
- Registration Number
- KCT0000925
- Lead Sponsor
- Yonsei University Health System, Gangnam Severance Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 96
1.Subjects who have ability to comprehend the contents of study and before participating in trial and have willingness to sign of informed consent in writing
3.20= age =60
4.A patient has symptom of acute low back pain 4= VAS
1.Subjects who cannot prohibit anti-inflammatory drug, painkiller or muscle relaxants during clinical trial
2.Chronic rheumatoid arthritis patients
3.Patients having a medical history of hypersensitivity to Eperisone Hydrochloride
4.Subject having a hereditary problem such as galactose intolerance, Lapp lactase deficiency, or glucose galatose malabsorption
5.Participation in other studies before 60 days of first dosing
6.Female patients having positive pregnancy test, lactating women,planning pregnancy during clinical trial
7.Inadequate subject for the clinical trial by the investigator's decision
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method VAS improvement of pain at rest;VAS improvement of pain on movement;VAS improvement of pain at night
- Secondary Outcome Measures
Name Time Method Change of Modified Schober test;Change of Lateral Body Bending test;Change of Oswestry Disability Index;Change of EuroQol by patients;Overall pain improvement by investigator